Margot DeFrance

Managing Director

Margot DeFrance leads investment marketing, relationship management, strategy & business development, and investor relations. Prior to transitioning to the financial industry, Margot was a fortune 500 pharmaceutical executive and a director for a non-profit where she managed products related to diagnostics and blood banking and negotiated licensing deals.

Ms. DeFrance has managed equity research, strategy and investment marketing at Smith Barney and Citi Capital Markets. In addition to these pursuits, she also authored “Endangered Species” (highlighting the impact of generic erosion on pharma valuations), and “Dancing on a Fault Line” (suggesting more diversified healthcare investing strategy due to pricing pressures, pipeline deficiencies, and politics).

Margot provides strategic advice, technology search, and investor messaging / capital introductions for innovative startups and mid-market companies through her consulting practice, Inflection Point Advisors.

‍

This material is intended for information purposes only, and does not constitute investment advice, a recommendation or an offer or solicitation to purchase or sell any securities, funds or strategies to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. The opinions expressed are as of January 2024 and are subject to change without notice. Reliance upon information in this material is at the sole discretion of the reader.
‍
‍Investing involves risk, including possible loss of principal. Private placements are exempt from the registration requirements of the Securities Act of 1933 and public disclosure requirements, as long as certain requirements are met and, as such, carry a high degree of risk. Private placements being promoted are illiquid investments, with no guarantee of returns, distributions and/or interest payments, and it is possible to lose some or all of the investment. The Issuer may require more capital in the future to continue growing, with no guarantee that the Issuer will be successful in securing it. There is more information about the risks of private placements on FINRA's website.
‍
Funds that concentrate investments in specific industries, sectors, markets or asset classes may underperform or be more volatile than other industries, sectors, markets or asset classes and than the general securities market. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.

For additional disclosure information and to view the Firm's Customer Relationship Summary, please visit our disclosure page.